The aim of this study was to establish reference values for mucociliar
y clearance and mucociliary clearance reserve capacity as determined b
y beta (2)-adrenergic agonist-induced increase in mucociliary clearanc
e. We studied 62 healthy females (n=33) and males (n=29). Their ages r
anged evenly between 18 and 84 years. Fifty-three of the subjects were
life-long non-smokers, while nine were ex-smokers. Multiple linear re
gression analyses showed that mucociliary clearance was significantly
faster when the radioaerosol was deposited in the central airways than
when it was deposited in the peripheral airways, and faster in life-l
ong non-smokers than in ex-smokers. There was no influence of age, and
no convincing association with sex. The variation was less within tha
n between subjects. Mean mucociliary clearance reserve capacity was 21
.3% (SD: 10.0%, P<0.0001). The beta (2) agonist-induced increase in lu
ng mucociliary clearance was significantly larger (P<0.05) than the st
imulation which has previously been reported in patients with asthma,
bronchiectasis or cystic fibrosis. The signal-to-noise ratio of the mu
cociliary clearance reserve capacity in relation to measurement of bas
eline mucociliary clearance indicates that measurement of mucociliary
clearance reserve capacity may be a more efficient means of distinguis
hing between ''normal'' and ''abnormal'' mucociliary clearance than si
ngle measurement of baseline mucociliary clearance.